| Walmart Pharmacy 10-7242 | |
| 367 W Main St, Farmington, Arkansas 72730 | |
| (479) 267-0043 |
| Name | Walmart Pharmacy 10-7242 |
|---|---|
| Organization Name | Walmart Inc |
| Location | 367 W Main St, Farmington, Arkansas 72730 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (479) 267-0043 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Cell Therapeutics, Inc. (CTI) has announced that the U.S. Food and Drug Administration (FDA) has accepted for filing and review, and has granted priority review status for, the supplemental Biologics License Application (sBLA) for use of Zevalin ([90Y]-ibritumomab tiuxetan) as consolidation therapy for patients with follicular B-cell non-Hodgkin's lymphoma who achieve a response to first-line therapy. Priority review is granted by the FDA for a treatment that addresses a significant unmet medical need.
Researchers in Scotland have conducted a study showing that the proportion of deaths due to coronavirus disease 2019 (COVID-19) resulting from infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) increased in the UK after November 2020.
Magellan GPS announced today the launch of its first two products in its new fitness line: Switch and Switch Up. Designed to meet the needs of runners, cyclists, and multisport athletes, the new Switch Series is a powerful, adaptable, and customizable family of crossover GPS watches that will integrate seamlessly with third party sites.
In the Americas, primate species likely to harbor Zika - and potentially transmit the virus - are common, abundant, and often live near people. So reports a new study published today in Epidemics. Findings are based on an innovative model developed by a collaborative team of researchers from Cary Institute of Ecosystem Studies and IBM Research through its Science for Social Good initiative.
The National Health Service in the UK is being put under considerable pressure by Cancer charities to widen access to a promising new class of breast cancer drug as new evidence suggests the latest treatment is far superior to Tamoxifen, the long established premier drug for women with the early stage of the disease.
› Verified 8 days ago
| NPI Number | 1720492564 |
| Organization Name | WALMART INC. |
| Doing Business As | WALMART PHARMACY 10-7242 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 367 W Main St, Farmington, AR 72730 |
| Phone Number | 479-267-0043 |
News Archive
Cell Therapeutics, Inc. (CTI) has announced that the U.S. Food and Drug Administration (FDA) has accepted for filing and review, and has granted priority review status for, the supplemental Biologics License Application (sBLA) for use of Zevalin ([90Y]-ibritumomab tiuxetan) as consolidation therapy for patients with follicular B-cell non-Hodgkin's lymphoma who achieve a response to first-line therapy. Priority review is granted by the FDA for a treatment that addresses a significant unmet medical need.
Researchers in Scotland have conducted a study showing that the proportion of deaths due to coronavirus disease 2019 (COVID-19) resulting from infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) increased in the UK after November 2020.
Magellan GPS announced today the launch of its first two products in its new fitness line: Switch and Switch Up. Designed to meet the needs of runners, cyclists, and multisport athletes, the new Switch Series is a powerful, adaptable, and customizable family of crossover GPS watches that will integrate seamlessly with third party sites.
In the Americas, primate species likely to harbor Zika - and potentially transmit the virus - are common, abundant, and often live near people. So reports a new study published today in Epidemics. Findings are based on an innovative model developed by a collaborative team of researchers from Cary Institute of Ecosystem Studies and IBM Research through its Science for Social Good initiative.
The National Health Service in the UK is being put under considerable pressure by Cancer charities to widen access to a promising new class of breast cancer drug as new evidence suggests the latest treatment is far superior to Tamoxifen, the long established premier drug for women with the early stage of the disease.
› Verified 8 days ago
News Archive
Cell Therapeutics, Inc. (CTI) has announced that the U.S. Food and Drug Administration (FDA) has accepted for filing and review, and has granted priority review status for, the supplemental Biologics License Application (sBLA) for use of Zevalin ([90Y]-ibritumomab tiuxetan) as consolidation therapy for patients with follicular B-cell non-Hodgkin's lymphoma who achieve a response to first-line therapy. Priority review is granted by the FDA for a treatment that addresses a significant unmet medical need.
Researchers in Scotland have conducted a study showing that the proportion of deaths due to coronavirus disease 2019 (COVID-19) resulting from infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) increased in the UK after November 2020.
Magellan GPS announced today the launch of its first two products in its new fitness line: Switch and Switch Up. Designed to meet the needs of runners, cyclists, and multisport athletes, the new Switch Series is a powerful, adaptable, and customizable family of crossover GPS watches that will integrate seamlessly with third party sites.
In the Americas, primate species likely to harbor Zika - and potentially transmit the virus - are common, abundant, and often live near people. So reports a new study published today in Epidemics. Findings are based on an innovative model developed by a collaborative team of researchers from Cary Institute of Ecosystem Studies and IBM Research through its Science for Social Good initiative.
The National Health Service in the UK is being put under considerable pressure by Cancer charities to widen access to a promising new class of breast cancer drug as new evidence suggests the latest treatment is far superior to Tamoxifen, the long established premier drug for women with the early stage of the disease.
› Verified 8 days ago
Walmart Pharmacy 10-7242 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 367 W Main St, Farmington, Arkansas 72730 Phone: (479) 267-0043 |